Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Recruiting

Phase 2

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionAdenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Sponsor:

New York Medical College

Code:

NCT03266627

Conditions

Adenovirus

Primary Immune Deficiency Disorder

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

cytotoxic t-lymphocytes

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by New York Medical College on 2024-11-14.